Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis.
Thomas KarlasDavid PetroffJürgen FeisthammelSebastian BeerMatthias BlüherTatjana SchützRalf LichtinghagenAlbrecht HoffmeisterJohannes WiegandPublished in: Obesity surgery (2022)
One year of DJBL therapy is associated with relevant improvements in non-invasive markers of steatosis and NASH, but not fibrosis, and is accompanied by a substantial number of complications. Given the lack of alternatives, DJBL deserves further attention.